BTG2 and pancreatic neoplasm: More importantly, the tumor-suppressive effects of DSCR9 overexpression on pancreatic cancer cells were significantly reversed by miR-21-5p overexpression, whereas the suppressive effects of DSCR9 overexpression on BTG2 expression were reversed by miR-21-5p overexpression.